Add 2 More Reports For 20% off

Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Dry Eye Syndrome Market Outlook

The global dry eye syndrome market size was worth USD 4.26 billion in 2023. The market is further expected to grow at a CAGR of 6.8% between 2024 and 2032 to reach a value of approximately USD 7.72 billion by 2032. 

Dry Eye Syndrome Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The R&D partnership and the Choice and Lice agreement for the development of gene therapy vectors for retinal diseases were concluded in June 2020 with Santen Pharmaceutical Co., Ltd. and Oxford Biomedica. This R&D partnership primarily aims to produce pre-clinical evidence for OXB's idea for the treatment of inherited retinal diseases using lentiviral vectors. This will support the company's product growth, which will also aid the growth of the overall market.

Market Segmentation

Dry eye syndrome, scientifically identified as keratoconjunctivitis sicca (KCS), refers to a distinguishing concept of the person's eye surface that lacks lubrication or moisture. It is a severe disease that can affect virtually everyone. Several dry eye signs include nausea and burning sensations, eyes swollen, red eyes, fatigued eyes, itchy eyes, and photophobia, among others. In addition, watery eyes may also be a symptom, as a dry eye surface over-stimulates the development of watery tears to alleviate the dryness. Dry eye disease can be caused by excessive use of computers, allergies, obesity, menopause, smoking, LASIK eye surgery, and hormone replacement therapy, among others.

Dry Eye Syndrome Market by Drug Type

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Based on disease type, the market is divided into the following:

  • Evaporative 
  • Aqueous 

Based on drug type, the market can be divided into the following:

  • Anti-Inflammatory Drugs
  • Lubricant Eye Drops
  • Autologous Serum Eye Drops 

On the basis of product, the industry can be segmented into:

  • Liquid Drops 
  • Gel 
  • Liquid Wipes 
  • Eye Ointment 
  • Others

Based on distribution channel, the market can be divided into the following:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies 

The regional markets for the product include North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Dry Eye Syndrome Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Analysis

The development of the global dry eye syndrome market is largely due to the rise in the widespread occurrence of dry eye syndrome, which is attributed to a variety of factors. The increasing geriatric population around the world has resulted in a rise in the incidence of the syndrome because tear glands weaken because of their ageing and cannot produce enough tear fluid to hold a lubricating film on the eyes. Another key factor for the rising incidence of dry eye syndrome is the higher prevalence of other conditions, which can affect the functioning of the eye like diabetes. The changes in patient's blood composition due to diabetes will adversely affect the weeping glands, causing dry eye syndrome. Many diseases that can cause dry-eye syndrome indirectly include vitamin A deficiency, lupus, thyroid disease, and rheumatoid arthritis. The growing occurrence of such diseases in the market is expected to aid the overall market growth.

Competitive Landscape 

The report gives a detailed analysis of the following key players in the global dry eye syndrome market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Akorn, Incorporated.
  • AbbVie 
  • Auven Therapeutics
  • Nicox S.A.
  • Novartis AG 
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Disease Type
  • Drug Type
  • Product
  • Distribution Channel
  • Region
Breakup by Disease Type
  • Evaporative Dry Eye Syndrome
  • Aqueous Dry Eye Syndrome
Breakup by Drug Type
  • Anti-Inflammatory Drugs
  • Lubricant Eye Drops
  • Autologous Serum Eye Drops
Breakup by Product
  • Liquid Drops
  • Gel
  • Liquid Wipes
  • Eye Ointment
  • Others
Breakup by Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Akorn, Incorporated.
  • AbbVie 
  • Auven Therapeutics
  • Nicox S.A.
  • Novartis AG 
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The market is projected to grow at a CAGR of 6.8% between 2024 and 2032.

The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach about USD 7.72 billion by 2032.

The major drivers of the market are the rising occurrence of dry eye syndrome, and changing lifestyles.

The key trends guiding the growth of the market include the rising research and development activities in the industry and increasing geriatric population.

The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

Evaporative and aqueous dry eye syndromes are the major disease types in the market.

Anti-inflammatory drugs, lubricant eye drops, and autologous serum eye drops are the major drug types in the market.

Liquid drops, gel, liquid wipes, and eye ointment, among others, are the major products in the market.

The major distribution channels in the market are hospital pharmacies, retail pharmacies, and online pharmacies.

The major players in the  global dry eye syndrome market are Akorn, Incorporated., AbbVie, Auven Therapeutics, Nicox S.A., and Novartis AG, among others.

In 2023, the global dry eye syndrome market attained a value of nearly USD 4.26 billion.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63 287899028, +63 967 048 3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124